🇺🇸 FDA
Patent

US 8883155

Methods for treating hematopoietic malignancies

granted A61KA61K31/52A61K38/1793

Quick answer

US patent 8883155 (Methods for treating hematopoietic malignancies) held by The Regents of the University of California expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/52, A61K38/1793, A61K39/39558, A61K45/06